Afya Limited (AFYA) – What Are Researchers Saying About This Stock?

Shares of Afya Limited (NASDAQ:AFYA) have received an average rating of “Hold” from the nine analysts that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $15.18.

AFYA has been the subject of a number of analyst reports. Citigroup upgraded shares of Afya from a “neutral” rating to a “buy” rating and decreased their price objective for the company from $16.00 to $12.00 in a report on Tuesday, November 3rd. Morgan Stanley upgraded shares of Afya from an “underweight” rating to an “equal weight” rating and set a $12.60 target price on the stock in a report on Thursday, November 5th. JPMorgan Chase & Co. reduced their price target on shares of Afya from $19.00 to $17.50 and set an “overweight” rating on the stock in a research report on Tuesday, November 3rd. Bank of America raised shares of Afya from a “neutral” rating to a “buy” rating and set a $16.00 price target for the company in a report on Thursday, October 29th. Finally, Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 3rd.

Afya Price Performance

Afya stock opened at $10.32 on Friday. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $967.19 million, a P/E ratio of 6.07, a PEG ratio of 1.66 and a beta of 0.43. The business has a 50-day moving average of $12.82 and a 200-day moving average of $14.00. Afya has a 1 year low of $9.66 and a 1 year high of $16.16.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. Afya had a net margin of 20.48% and a return on equity of 17.43%. The business had revenue of $187.80 million for the quarter, compared to the consensus estimate of $189.62 million. On average, equities analysts anticipate that Afya will post 1.68 EPS for the current year.

Insider Transactions at Afya

In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of the business’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the transaction, the insider directly owned 35,000 shares of the company’s stock, valued at approximately $465,500. The trade was a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.80% of the company’s stock.

Hedge Funds Weigh In On Afya

Institutional investors have recently modified their holdings of the business. R Squared Ltd grew its position in shares of Afya by 37.0% in the 3rd quarter. R Squared Ltd now owns 60,114 shares of the company’s stock valued at $724,000 after purchasing an additional 16,250 shares during the period. Marshall Wace LLP bought a new stake in Afya during the 3rd quarter worth approximately $399,000. Engineers Gate Manager LP bought a new stake in Afya during the 2nd quarter worth approximately $325,000. Finally, Public Employees Retirement System of Ohio bought a new stake in Afya during the 2nd quarter worth approximately $67,000. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.